Viewing Study NCT01633112


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2026-03-12 @ 9:17 PM
Study NCT ID: NCT01633112
Status: TERMINATED
Last Update Posted: 2019-05-28
First Post: 2012-06-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-08-09
Start Date Type: ACTUAL
Primary Completion Date: 2018-04-30
Primary Completion Date Type: ACTUAL
Completion Date: 2018-04-30
Completion Date Type: ACTUAL
First Submit Date: 2012-06-29
First Submit QC Date: None
Study First Post Date: 2012-07-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-04-29
Results First Submit QC Date: None
Results First Post Date: 2019-05-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-04-29
Last Update Post Date: 2019-05-28
Last Update Post Date Type: ACTUAL